APCU25OS20 Incidence of cardiovascular events in patients receiving hematopoietic stem cell transplant (HSCT) in HCTM: a retrospective cohort study

2026 Open access

Read full text
Authors: Ahmad Farhan A, Mohd Shawal FM, S Fadilah AW
DOI: 10.1136/openhrt-2025-apcu.20
Cited by: 0

Abstract

Abstract Background Hematopoietic stem cell transplantation (HSCT) is a curative therapy for hematologic malignancies, yet cardiovascular events (CEs) remain a significant complication, particularly in Asian populations, where data are limited.Objectives To determine the incidence and risk factors for short-term (

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Chemotherapy-induced cardiotoxicity and mitigation Transplantation: Methods and Outcomes

Publication details

Pages
A9.1–A9
Publication date
1 February 2026
Language
EN